sub:assertion { d:DB05742v:identifier "DB05742" ; v:namespace "drugbank" ; v:uri "http://bio2rdf.org/drugbank:DB05742" ; v:x-identifiers.org <http://identifiers.org/drugbank/DB05742> ; dv:drugbank-id "DB05742" ; dv:x-cas <http://bio2rdf.org/cas:> ; dct:description """AGS-004 is a personalized RNA-loaded dendritic cellbased immunotherapy that is designed to stimulate the patientâs immune system to target and destroy the patientâs own unique viral burden. Non-personalized HIV immunotherapies are unable to raise cytotoxic T lymphocytes against HIV antigens, fail to induce T cell memory, and, most importantly, do not provide antiviral protection against the patient's own particular virus. A personalized immunotherapy addresses these issues because it is able to capture private viral mutations, providing a matched, complete immune response for each individual HIV patient. This approach may overcome the weaknesses of other available therapies and therefore could result in a better chance of success for HIV treatment."""@en ; dct:identifier "drugbank:DB05742" ; dct:title "AGS-004"@en ; adv:Drug ; rdfs:label "AGS-004 [drugbank:DB05742]"@en ; rdfs:seeAlso <http://www.drugbank.ca/drugs/DB05742> . }